Man Group’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Man Group’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-42,411	Closed	-$268K	–	2324
2022 Q4	$268K	Buy	+42,411	New	+$235K	﹤0.01%	1683
2018 Q3	–	Sell	-2,173	Closed	-$103K	–	2266
2018 Q2	$103K	Buy	2,173 +104	+5%	+$5.77K	﹤0.01%	2068
2018 Q1	$127K	Buy	+2,069	New	+$109K	﹤0.01%	1953

Man Group's FSTX Position: Q1 2023 in Review

Man Group sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 42,411 shares — an estimated $268K sold.

Man Group first reported a position in FSTX in Q1 2018 and held it in 3 quarters. The position peaked at $268K in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Man Group reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Man Group sold 42,411 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $268K.
Man Group first reported a position in F-star Therapeutics, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
Man Group's F-star Therapeutics, Inc. Common Stock position peaked at $268K in Q4 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.